Company: FVN
Filing Date: 2025-04-14
Form Type: DRS/A
Source: 0001829126-25-002616
Chunk: 142

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-04-14
Form: DRS/A
Chunk 142
---
 VIWO’s home country (assuming New VIWO converts to foreign private issuer on the first available determination date). Certain corporate governance practices in the Cayman Islands, which is New VIWO’s home country, may differ significantly from the Nasdaq corporate governance listing standards. For instance, New VIWO will not be required to:

| ● | have a majority of the board be independent (although all of the members of the audit committee must be independent under the Exchange Act);                                                                                                                                                       |
| ● | have a compensation committee or a nominations or corporate governance committee consisting entirely of independent directors; or                                                                                                                                                                  |
| ● | have regularly scheduled executive sessions with only independent directors each year.                                                                                                                                                                                                             |
|   | In addition, New VIWO currently does not intend to hold an annual general meeting or annual director elections, which may severely limit shareholders’ ability to influence corporate governance decisions, including changing directors, approving mergers, or amending constitutional documents. |

VIWO currently follows and New VIWO may continue to follow its home country practices with respect to corporate governance. As a result of New VIWO’s reliance on the “foreign private issuer” exemptions, New VIWO shareholders may be afforded less protection than they otherwise would enjoy under the Nasdaq corporate governance listing standards applicable to U.S. domestic issuers.

<div align='center'>77</div>

Risks Related to the Business Combination and being a Public Company

Going public through a merger rather than an underwritten offering presents risks to unaffiliated investors. Subsequent to our completion of the business combination, we may be required to take write-downs or write-offs, restructuring and impairment or other charges that could negatively affect our financial condition, results of operations and share price, which could cause you to lose some or all of your investment.

Going public through a merger rather than an underwritten offering, as VIWO is seeking to do, presents risks to unaffiliated investors. Such risks include the absence of a due diligence investigation conducted by an underwriter that would be subject to liability for any material misstatements or omissions in a registration statement. We cannot assure you that due diligence conducted in connection with this business combination has identified all material issues that may be present in VIWO’s business prior to the completion of the business combination during the course of our due diligence, that it would be possible to uncover all material issues through a customary amount of due diligence, or that factors outside of VIWO’s and Future Vision’s control will not later arise. As a result of these factors, we may be